Article (Scientific journals)
A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosoldevices on muscarinic bronchoconstriction in healthy cats
Leemans, Jérôme; Kirschvink, Nathalie; Bernaerts, Frederique et al.
2009In Veterinary Journal, 180, p. 236–245
Peer Reviewed verified by ORBi
 

Files


Full Text
LeemansJ_TheVetJ_2009_b.pdf
Publisher postprint (331.77 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Feline; Barometric whole-body plethysmography; Bronchial responsiveness; Inhaled bronchodilators
Abstract :
[en] This study compared the duration and magnitude of the antispasmodic effects of salmeterol SLM), salbutamol (SAL), ipratropium bromide (IB) and the combination of SAL and IB (SAL/IB) against carbachol-induced bronchoconstriction in healthy cats, and investigated the gain in efficacy using a two or fourfold increase in drug dosages. The drug regimens used were: (1) LM 25 lg, SAL 100 lg, IB 20 lg and SAL/IB 100 lg/20 lg for bronchodilators delivered by a metered-dose inhaler (MDI); (2) SAL 3.75 mg and IB 62.5 lg for nebulised (NEB) medications. To monitor the bronchodilator effect, airway responsiveness was assessed at different time points using barometric whole-body plethysmography and calculation of the concentration of inhaled carbachol inducing a 300% increase of baseline Penh (enhanced pause), an estimator of airflow limitation Maximum C-Penh300 was recorded 15 min after NEB SAL, IB MDI, NEB IB and 1 h after SAL MDI and 4 h after SLM MDI, respectively. C-Penh300 was significantly different from control values (without treatment) up to 24 h for SLM MDI, 8 h for IB MDI and 4 h for other drugs. In terms of efficacy, SAL/IB MDI showed a synergistic antispasmodic effect at 15 min, 4 h and 8 h after administration. A fourfold increase of the initial dose of IB MDI and NEB IB significantly increased C-Penh300. Despite a fourfold dose increase, SLM displayed the weakest degree of bronchoprotection compared to other bronchodilators. The study provides evidence that inhaled bronchodilators are efficient at preventing muscarinic-induced bronchospasm in healthy cats and that SAL and IB appear to be short-acting bronchodilators in contrast to SLM.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Leemans, Jérôme ;  Université de Liège - ULiège > Département de sciences fonctionnelles > Pharmacologie, pharmacothérapie et toxicologie
Kirschvink, Nathalie
Bernaerts, Frederique ;  Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Clercx, Cécile  ;  Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Cambier, Carole ;  Université de Liège - ULiège > Département de sciences fonctionnelles > Département de sciences fonctionnelles
Gustin, Pascal ;  Université de Liège - ULiège > Département de sciences fonctionnelles > Pharmacologie, pharmacothérapie et toxicologie
Language :
English
Title :
A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosoldevices on muscarinic bronchoconstriction in healthy cats
Publication date :
2009
Journal title :
Veterinary Journal
ISSN :
1090-0233
eISSN :
1532-2971
Publisher :
Elsevier
Volume :
180
Pages :
236–245
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 March 2009

Statistics


Number of views
41 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
35
Scopus citations®
without self-citations
30
OpenCitations
 
24

Bibliography


Similar publications



Contact ORBi